Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer

Anticancer Research

Volumn 20, Issue 2 B, 2000, Pages 1085-1091

  Öberg, Åke ^a   Höyhtyä, Matti ^b   Tavelin, Björn ^a   Stenling, Roger ^a   Lindmark, Gudrun ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b Diabor Oy   (Finland)

Author keywords

Colorectal cancer; Matrix metalloproteinases; MMP 2; MMP 9; Prognosis; Staging; TIMP 1; TIMP 2; Tissue inhibitors of matrix metalloproteinases

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECTAL NEOPLASMS; REFERENCE VALUES; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR MARKERS, BIOLOGICAL;

EID: 0344002712     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Birkedal-Hansen H: Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7: 728-735, 1995.
2. Parsons SL, Watson SA, Brown PD, Collins HM and Steele RJC: Matrix metalloproteinases. Br J Surg 84: 160-166, 1997.
3. Liotta LA and Stetler-Stevenson WG: Metalloproteinases and cancer invasion. Semin L Cancer Biol 1: 99-106, 1990.
4. De Clerk YA, Shimada H, Taylor SM and Langley KE: Matrix metalloproteinases and their inhibitors in tumor progression. Ann N Y Acad Sci 732: 222-232, 1994.
5. van der Stappen JWJ, Hendriks T and Wobbes T: Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors. Int J Cancer 45: 1071-1078, 1990.
6. Levy AT, Cioce V, Sobel ME, Garbisa S, Grigione WF and Liotta LA: Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res 51: 439-444, 1991.
7. Urbanski SJ, Edwards DR, Hershfeield N, Huchcroft SA, Shaffer E, Sutherland L and Kossakowska AE: Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia. Diagn Mol Pathol 2: 81-89, 1993.
8. Höyhtyä M, Fridman R, Komarek D, Porter-Jordan K, Stetler-Stevenson WG, Liotta LA and Liang CM: Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int J Cancer 56: 500-505, 1994.
9. Newell KJ, Witty JP, Rodgers WH and Matrisian LM: Expression and localization of matrix- degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 10: 199-206, 1994.
10. Liabakk NB, Talbot I, Smith RA, Wilkinson K and Balkwill F: Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 56: 190-196, 1496.
11. Ring P, Johansson K, Hoyhtya M, Rubin K and Lindmark G: Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer - a predictor of tumour stage. Br J Cancer 76: 805-811, 1997.
12. Zeng ZS and Guillem JG: Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases. Br J Cancer 72: 575-582, 1995.
13. Manicourt DH, Fujimoto N, Obata K and Thonar EJM: Levels of circulating collagenase, stromelysine-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Arthritis Rheum 38: 1031-1039, 1995.
14. Muzzillo DA, Imoto M, Fukuda Y, Kuyama Y, Saga S, Nagai Y and Hayakawa T: Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases. J Gastroenterol Hepatol 8: 437-441, 1993.
15. Kasahara A, Hayashi N, Mochizuki K, Oshita M, Katayama K, Kato M, Masuzawa M, Yoshihara H, Naito M, Miyamoto T, Inoue A, Asai A, Hijioka T, Fusamoto H and Kamada T: Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis. J Hepatol 26: 574-583, 1997.
16. Kikuchi K, Kubo M, Sato S, Fujimoto M and Tamaka K: Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis. J Am Acad Dermatol 33: 973-978, 1995.
17. Akiyama K, Shikata K, Sugimoto H, Matsuda M, Shikata Y, Fujimoto N, Obata K, Matsui H and Makino H: Changes in serum concentrations of matrix metalloproteinases, tissue inhibitors of metalloproteinases and type IV collagen in patients with various types of glomerulonephritis. Res Commun Mol Pathol Pharmacol 95: 115-127, 1997.
18. Zucker S, Lysik RM, Zarrahi MH, Stetler-Stevenson W, Liotta L, Birkedal-Hansen H, Mann W and Furie M: Type IV collagenase/ gelatinase (MMP-2) is not increased in plasma of patients with cancer. Cancer Epidemiol Biomarkers Prev 1: 475-479, 1992.
19. Endo K, Maehara Y, Baba H, Yamamoto M, Tomisaki S, Watanabe A, Kakeji Y and Sugimachi K: Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer. Anticancer Res 17: 2253-2258, 1997.
20. De Nictolis M, Garbisa S, Lucarini G, Goteri G, Masiero L, Ciavattini A, Garzetti G, Stetler-Stevenson W, Fabris G, Biagini G and Prat J: 72-kilodalton type IV collagenase, type IV collagen, and Ki67 antigen in serous tumors of the ovary: A clinicopathologic, immunohistochemical, and serological study. Int J Gynecol Pathol 15: 102-109, 1996.
21. Hayasaka A, Suzuki N, Fujimoto N, Iwama S, Fukuyama E, Kanda Y and Saisho H: Elevated plasma levels of matrix metalloproteinase-9 (92-kD type IV collagenase/gelatinase B) in hepatocellular carcinoma. Hepatology 24: 1058-1062, 1996.
22. Gohji K, Fujimoto N, Komiyama T, Fujii A, Ohkawa J, Kamidono S and Nakajima M: Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma. Cancer 78: 2379-2387, 1996.
23. Gohji K, Fujimoto N, Fujii A, Komiyama T, Okawa J and Nakajima M: Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinase-2 ratio in recurrence of urothelial cancer after complete resection. Cancer Res 56: 3196-3198, 1996.
24. Baker T, Tickle S, Wasan H, Docherty A, Isenberg D and Waxman J: Serum metalloproteinases and their inhibitors: markers for malignant potential. Br J Cancer 70: 506-512, 1994.
25. Jung K, Nowak L, Lein M, Priem F, Schnorr D and Loening SA: Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase- 1 and the complex of metalloproteinase- 1/tissue inhibitor in plasma of patients with prostate cancer. Int J Cancer (Pred Oncol) 74: 220-223, 1997.
26. Zucker S, Lysik RM, Zarrabi MH and Moll-U: Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 53: 140-146, 1993.
27. Garbisa S, Scargliotti G, Masiero L, Di Francesco C, Caenazzo C, Onisto M, Micela M, Stetler-Stevenson WG and Liotta LA: Correlation of serum metalloproteinase levels with lung cancer metastases and response to therapy. Cancer Res 52: 4548-4549, 1992.
28. Zucker S, Lysik R, Dimassoni BS, Zarrabi H, Moll U, Grimson R, Tickle S and Docherty A: Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer. Cancer 76: 700-708, 1995.
29. Dukes CE and Bussey HJR: The spread of rectal cancer and its effect on prognosis. Br J Cancer 12: 309-320, 1958.
30. Lindmark G, Gerdin B, Pahlman L, Bergstrom R and Glimelius B: Prognostic predictors in colorectal cancer. Dis Colon Rectum 37: 1219-1227, 1994.
31. Nikkari ST, Hoyhtya M, Isola J and Nikkari T: Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol 149: 1427-1433, 1996.
32. Lein M, Nowak L, Jung K, Koenig F, Lichtinghagen R, Schnorr D and Loening S: Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood. Clin Biochem 30: 491-496, 1997.